Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-09-16 Rodgers Richard J Director Grant or award · Stock Option (right to buy) +90,000 90,000
2015-09-16 Cheong Kwang Soo Director Grant or award · Stock Option (right to buy) +90,000 90,000
2015-09-16 CARTHY MARK Director Grant or award · Stock Option (right to buy) +90,000 90,000
2015-09-16 Brandt Peter C. Director Grant or award · Stock Option (right to buy) +90,000 90,000
2015-09-16 Beever Charles Director Grant or award · Stock Option (right to buy) +90,000 90,000
2015-02-02 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +1,200,000 1,200,000
2015-01-23 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +1,100,000 1,100,000
2015-01-23 Jeong Tae Heum Chief Financial Officer Grant or award · Stock Option (right to purchase) +333,332 333,332
2015-01-23 Ahn Chang Ho Director Grant or award · Stock Option (right to purchase) +333,332 333,332
2015-01-12 Jeong Tae Heum Chief Financial Officer Exercise or conversion +49,800 $0.80 $40K 554,800
2015-01-12 Jeong Tae Heum Chief Financial Officer Sale −49,800 $0.91 $45K 505,000
2015-01-12 Jeong Tae Heum Chief Financial Officer Exercise or conversion · Stock Option (right to purchase) −49,800 182,728
2015-01-12 Ahn Chang Ho Director Exercise or conversion +48,444 $0.80 $39K 6,058,444
2015-01-12 Ahn Chang Ho Director Sale −48,444 $0.91 $44K 6,010,000
2015-01-12 Ahn Chang Ho Director Exercise or conversion · Stock Option (right to purchase) −48,444 549,151
2015-01-09 Jeong Tae Heum Chief Financial Officer Exercise or conversion +188,690 $0.80 $151K 693,690
2015-01-09 Jeong Tae Heum Chief Financial Officer Sale −188,690 $0.92 $173K 505,000
2015-01-09 Jeong Tae Heum Chief Financial Officer Exercise or conversion · Stock Option (right to purchase) −188,690 232,528
2015-01-09 Ahn Chang Ho Director Exercise or conversion +186,212 $0.80 $149K 6,196,212
2015-01-09 Ahn Chang Ho Director Sale −186,212 $0.92 $170K 6,010,000

Page 18 of 22 · 437 trades